Taken together, we observed a heterogeneity in the expression of fibroblast markers in our cohort and three proteins (αSMA, CAV1 and CD90) are suitable markers for determining fibroblast activation status to differentiate CAFs from NFs in colorectal cancer. This evidence concerns the gene THY1 and colorectal cancer.